AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 237 filers reported holding AMICUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $259 | -99.8% | 21,181 | +76.2% | 0.03% | +68.4% |
| Q2 2022 | $129,000 | -88.0% | 12,023 | -89.3% | 0.02% | -82.7% |
| Q3 2021 | $1,077,000 | +94.4% | 112,813 | +101.2% | 0.11% | +19.6% |
| Q1 2021 | $554,000 | -6.4% | 56,077 | +33.7% | 0.09% | -7.1% |
| Q3 2020 | $592,000 | +453.3% | 41,952 | +213.8% | 0.10% | +607.1% |
| Q3 2019 | $107,000 | -65.4% | 13,370 | -34.8% | 0.01% | -33.3% |
| Q3 2017 | $309,000 | – | 20,506 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |